Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label treatments. Show all posts
Showing posts with label treatments. Show all posts
Thursday, March 29, 2012

Medscape: Targeting the Epigenome in Ovarian Cancer: Abstract and Introduction

›
Targeting the Epigenome in Ovarian Cancer: Abstract and Introduction From Future Oncology Targeting the Epigenome in Ovarian Cancer ...
Wednesday, February 29, 2012

abstract: Radiation Oncology Quality: Aggressiveness of Cancer Care Near the End of Life

›
Radiation Oncology Quality: Aggressiveness of Cancer Care Near the End of Life Purpose Quality in cancer care is an issue that has come t...
Wednesday, January 18, 2012

short abstract: Gynecological cancer: True progress in ovarian cancer or just the tip of the iceberg?

›
Blogger's Note:  requires subscription to view full text ($$$)  Gynecological cancer: True progress in ovarian cancer or just the ti...
Saturday, January 07, 2012

When a Decision Must Be Made: Role of Computer Modeling in Clinical Cancer Research

›
Every day, multidisciplinary oncology teams make dozens of treatment decisions that may have a tremendous impact on a patient's ...
Saturday, May 28, 2011

abstract: Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer

›
CONCLUSIONS: Combined weekly cDC ( concurrent docetaxel and carboplatin ) appeared to be cost-effective compared with sDC ( sequential ...
Thursday, February 24, 2011

Oncology STAT on IP chemo & dense dose regime | Cancer Survivors Network (discusses Avastin, Taxol, (Japanese study), clear cell, IP....)

›
Ovarian Cancer—New Thinking on Old Regimens 2011 Feb 23, Nelson Teng
Monday, May 17, 2010

full access: abstract/pdf file: Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions

›
Saturday, April 24, 2010

Uncertainty in Assessing Value of Oncology Treatments -- The Oncologist

›
abstract: Patients, clinicians, payers, and policymakers face an environment of significant evidentiary uncertainty as they attempt to achi...
Saturday, April 17, 2010

Impact of the Cost of Cancer Treatment: An Internet-Based Survey -- Markman et al (U.S.)

›
Note: ovarian cancer patients were not included in this study Conclusion: This survey suggests that a substantial proportion of patients...
Thursday, April 15, 2010

Advanced ovarian carcinoma: Does a high-dose short-duration schedule of paclitaxel trump prolonged low-dose therapy? - Cancer Network

›
Note: This is a good discussion debating pros/cons (requires registration to view/free) - some excerpts from article: Point / Counterpoi...
Monday, April 05, 2010

uTube - Bradley J. Monk, MD, University of California Irvine talks about early stage ovarian cancer including clear cell SGO

›
Note: the title on this video is wrong
Saturday, February 06, 2010

The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study

›
Abstract Objectives A prior clinical trial on early-stage high risk ovarian cancer showed a lower recurrence rate in those treated with si...
Saturday, January 30, 2010

videos: The Chemotherapy Foundation Symposium

›
Note : there are some key videos (free to view) from a variety of subjects Meeting Archives Chemotherapy Foundation Symposium XXVI Nov...
Thursday, January 28, 2010

A Revision Of The EU Clinical Trials Directive Supported By European Cancer Organization

›
"Certain groups of patients have been particularly hard hit: children, patients with rare cancers, patients who would profit greatly f...
Tuesday, January 19, 2010

full free access: Targeting the EGF Receptor for Ovarian Cancer Therapy

›
Note: numerous different treatments are discussed